<DOC>
	<DOCNO>NCT00769184</DOCNO>
	<brief_summary>This 12 week bilateral study , consist 6 week treatment 6 week follow-up . The purpose study compare safety effectiveness combine follow high potency topical corticosteroid treatment LCD treatment moderate-to-severe localized plaque psoriasis .</brief_summary>
	<brief_title>Combining Topical Corticosteroid LCD Treatment Localized Plaque Psoriasis</brief_title>
	<detailed_description>Superpotent topical corticosteroid clobetasol propionate highly effective treat plaque psoriasis indicate long term use due side effect . Therefore , steroid-sparing combination sequential regimen , corticosteroid get supplement non-steroid medication , calcipotriol tazarotene , become standard care , especially management localized psoriasis lesion . A new steroid-free 15 % liquor carbonis distillate ( LCD ) solution ( Psorent ) recently find successful 0.005 % calcipotriol cream ( Dovonex ) improve delay worsen psoriasis symptom control clinical trial . The goal pilot study evaluate LCD solution use combination acute topical corticosteroid therapy new steroid-sparing / enhance regimen . We hope explore compatibility , patient tolerability , clinical benefit use LCD solution treatment clobetasol propionate adult moderate severe plaque psoriasis . This randomized , double-blind , vehicle-controlled , bilateral study . Men woman 18 year age old , chronic plaque psoriasis affect less equal 10 % body surface area ( BSA ) area scalp , face , palm , sol , axilla , groin , recruit . Those Physician Global Assessment ( PGA ) score great 3 general good health qualify candidate . On one side body , LCD solution clobetasol propionate administer twice daily first 2 week treatment , follow 4 week LCD solution , follow 6 week treatment . On second half body , subject apply vehicle solution clobetasol propionate twice daily first 2 week , vehicle solution twice daily next four week , treatment next 6 week . Subjects evaluate week 2 , 4 , 6 , 8 , 10 12. investigator use PGA scale [ Clear ( 0 ) - Severe ( 5 ) ] determine treatment effect well Target Lesion assessment Erythema , Scaling , Induration overall severity [ None ( 0 ) - Very Severe ( 4 ) ] . patient also require complete Self-Assessment questionnaire psoriasis [ None ( 0 ) - Severe ( 6 ) ] . well assessment study solution [ Excellent ( 9 ) - Poor ( 1 ) ] . . Photographs take study visit adverse event monitor throughout study .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>18 year age older able provide write informed consent able attend study visit , apply medication , follow instruction moderate severe localize plaque psoriasis lesion ( &lt; 10 % BSA side body ) current treatment psoriasis hypersensitivity steroid , liquor carbonis detergens , alcohol , fragrance pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>chronic plaque psoriasis</keyword>
</DOC>